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Central Africa was the epicenter of the HIV type 1 (HIV-
1) pandemic. Understanding the early epidemic in the
Democratic Republic of the Congo, formerly Zaire, could
provide insight into how HIV evolved and assist vaccine
design and intervention efforts. Using enzyme immunosor-
bent assays, we tested 3,988 serum samples collected in
Kinshasa in the mid-1980s and confirmed seroreactivity by
Western blot. Polymerase chain reaction of gag p17, env
C2V3C3, and/or gp41; DNA sequencing; and genetic
analyses were performed. Gene regions representing all
the HIV-1 group M clades and unclassifiable sequences
were found. From two or three short gene regions, 37% of
the strains represented recombinant viruses, multiple infec-
tions, or both, which suggests that if whole genome
sequences were available, most of these strains would
have mosaic genomes. We propose that the HIV epidemic
was well established in central Africa by the early 1980s
and that some recombinant viruses most likely seeded the
early global epidemic. 
A
lmost 70% of all HIV type 1 (HIV-1) infections
worldwide are found in sub-Saharan Africa, and
central Africa is the only region where all HIV-1 groups
and group M subtypes have been identified (1–3). This
broad range of diversity suggested central Africa as the
epicenter of the HIV-1 pandemic (1). Phylogenetic recon-
struction has shown that HIV-1 appears in three distinct
lineages, groups M, N, and O (4–7), and each is believed
to have arisen through separate zoonotic infections with
chimpanzee simian immunodeficiency virus strains in cen-
tral Africa (8,9). HIV-1 group M viruses are primarily
responsible for the current global epidemic, while group O
infections are far fewer and generally found in west-central
Africa. Rare strains of group N viruses have been identi-
fied in Cameroon, also located in western equatorial
Africa. The group M viruses can be subdivided into 9 sub-
types, A–D, F–H, J, and K, and at least 14 circulating
recombinant forms (CRFs) (http://hiv-web.lanl.gov).
These phylogenetic clusterings of HIV strains, subtypes,
and CRFs are important records of the epidemic histories
of HIV, and they highlight the differences in their geo-
graphic distributions and areas where they are endemic.
Some of the earliest characterized whole-genome HIV-
1 sequences were collected in Zaire, currently called the
Democratic Republic of the Congo (DRC), in the late
1970s and early 1980s. During this time, Kinshasa, the cap-
ital of Zaire, was the largest urban area in central Africa,
with a population estimated at 2.5 million (10). From 1984
through 1991, the Zaire Department of Public Health con-
ducted a long-term collaborative HIV research and surveil-
lance program, Project SIDA, with the U.S. Department of
Health and Human Services and the Institute of Tropical
Medicine, Antwerp, Belgium. In 1991, Project SIDA was
abruptly terminated because of civil unrest. 
A low and stable HIV prevalence in Zaire/DRC from
1976–1997 (11,12) has been documented, despite social
and political upheavals. A genetic survey of HIV strains
performed in three regions of the DRC in 1997 demon-
strated a high diversity of HIV-1 group M subtypes (1).
Serum samples, available from Project SIDA, offered us
the opportunity to characterize HIV strains collected in
Kinshasa, Zaire, in 1984 and 1986 from employees at
Mama Yemo Hospital (13,14). The results provide new
insights into the dynamics of HIV infections in a low-
prevalence area where multiple subtypes cocirculate, early
in the global HIV-1 epidemic. 
Methods
Specimens and Serologic Analyses 
Serum samples acquired through Project SIDA from a
1984 and 1986 cross-sectional study of HIV infection
among hospital employees at Mama Yemo Hospital in
Kinshasa, Zaire were sent to the National Institutes of
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samples were sent to the Centers for Disease Control and
Prevention for serologic and genetic analysis. Specimens
numbered 30,000 through 32,000 were collected in 1984.
Samples numbered 33,000 through 35,585 were collected
among the same population in 1986. The specimens tested
represent a convenience sampling from the U.S. reposito-
ry at NIH and did not include all or only the samples in the
original study. The volumes of the specimens ranged from
approximately 200 µL to 4 mL. All samples were tested in
two separate whole viral-lysate enzyme immunosorbent
assay (EIA) for antibodies to HIV-1 and HIV-2 (Genetic
Systems, Redmond, WA). Samples with insufficient vol-
umes of serum were excluded from the analysis. Serum
specimens reactive by EIA were further tested by using an
HIV-1/2 Western blot assay (Genelabs Diagnostics,
Singapore, version 2.2). 
RNA Extraction, RT, and PCR 
Samples with sufficient volumes of serum for reverse
transcription–polymerase chain reaction (RT-PCR) ampli-
fication with three different sets of primers were selected
for further study. RNAwas extracted from serum by either
the NucliSens nucleic acid manual or automated protocols
(Organon Teknika, Boxtel, the Netherlands). RT-PCR was
performed by using the Promega RT kit (Promega,
Madison, WI) following the manufacturer’s protocol. PCR
reactions were placed in a GeneAMP 9600 thermocycler
(Perkin-Elmer Cetus, Norwalk, CT) for 35–40 cycles as
follows: 94°C for 30s, 55°C for 30s, and 72°C for 60s for
all but env gp41, which was at 50°C for 30s and 72°C for
60s, with the final extension at 72°C for 5 min. Nested
PCR products were electrophoresed in 1.5% agarose gels
(Gibco, Grand Island, NY) and visualized with ethidium
bromide staining. To avoid contamination, sample process-
ing and pre-PCR set-up were performed in different rooms
than post-PCR manipulations. All samples with discordant
phylogenies in different gene regions were verified by hav-
ing a different person reamplify and resequence the gene
regions from a second, unopened vial of serum, if avail-
able, or from the previously used vial. 
Primers 
For nested PCR amplification of 380-bp env C2V3C3
fragments, two sets were used: JH44F and JH35MR (out-
side) and JH33F and JH48R (nested) (15),and MK369 and
MK616 (outside) and MK650 and CO601 (nested) (15).
Primers for PCR amplification of a 475-bp gag p17 frag-
ment were CL1028 and AB1033 (outside) and CL1029 and
AB1032 (nested) (16); those used for a 460-bp fragment of
env  gp41 were GP40F1 and GP41R1 (outside) and
GP46F2 and GP48R2 or GP47R2 (nested) (17).
Sequencing PCR Products
The PCR-amplified products were purified with Qiagen
PCR purification kits (Qiagen Inc, Chatsworth, CA) and
directly sequenced by using the ABI PRISM Big Dye
Terminator Cycle Sequencing Ready Reaction Kit
(Applied Biosystems/Perkin Elmer, Foster City, CA) and
both forward and reverse nested PCR primers. The
sequencing reactions were purified by using the DyeEx
Spin Kit (Qiagen–USA, Valencia, CA) and resolved on a
377 ABI Automated DNA Cycle Sequencer (Applied
Biosystems).
Phylogenetic Analysis
Sequences were edited by using Sequencher Software
v.3.1 (Gene Codes Corp., Madison, WI) and aligned with
the Se-Al sequence alignment editor v.1.0 (http://evolve.
zoo.ox.ac.uk/software.html?id=seal). Sequences from
DRC collected in 1997 (1) were truncated to align with our
C2V3C3 sequences, and gaps and ambiguous positions
were removed, resulting in an alignment of 304 nt
sequences; the first 60 nt represented the C2 region. For
the outgroup in our tree, a consensus sequence represent-
ing the most common nucleotide at each position for each
subtype represented in the Zaire/DRC dataset was select-
ed, and then an overall DRC consensus sequence
(DRCcons) was inferred. No positions were undefined in
any of the consensus sequences, and no unclassified or
unresolved (subtype assignment) sequences were included
in the consensus sequence calculation. The Modeltest pro-
gram, v.3.1 (18) was used to test for a statistically justified
model of DNA substitution. The model of evolutionary
change used in the tree was Transversion Model (TVM) +
g (0.8575), where g is the shape parameter of the γ distri-
bution (heterogeneity among sites), and TVM is the model
of substitution whereby A↔G = C↔T and the other four
rates are unique. To search for the best tree with such a
large dataset (280 taxa) using the DRCcons sequence as
the outgroup, several relatively fast tree-building algo-
rithms were employed: Weighbor (http://www.t10.lanl.
gov/billb/weighbor/index.html), neighbor-joining (PAUP),
BioNJ (PAUP), and Fitch (PAUP). Trees derived from
these programs were input to the PAUP* (19) tree scores
program to compare the generated log likelihood scores.
The neighbor-joining tree program was selected for our
phylogenetic analysis since it had the best log likelihood
score, although it was not substantially better (Shimodaira-
Hasegawa test) than the BioNJ or Weighbor trees.
Genetic Distance Analysis 
Subtype and CRF designations were determined from
the phylogenetic analysis, and sequences grouping in sub-
types were input into the MEGA program version 2.1
(http://www.megasoftware.net) to calculate the means and
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using the Kimura 2P distance model.
Results
All 3,988 serum samples were tested by EIA, and 209
seroreactive samples were further tested by Western blot:
140 (3.5%) were HIV-1 seropositive, and 69 (1.7%) had
indeterminate Western blot patterns. Samples from infect-
ed persons who have not yet seroconverted can display
indeterminate Western blot patterns. If we were to assume
that all 69 persons with indeterminate Western blot results
were seroconverting at the time of sample collection, then
the upper limit for the frequency of HIV infections within
these early samples was still low at 5.2%. No HIV-2 EIA-
positive specimens were confirmed by HIV-2 Western blot
analysis.
The serum samples had been stored at –20°C for almost
2 decades, a temperature at which RNases are still active.
Because we were concerned that the quality of the RNA
would be compromised, we attempted to amplify three rel-
atively short gene regions: the p17 region of gag (474 bp)
and two env fragments, C2V3C3 (400 bp) and gp41 (460
bp). All serum specimens could not be amplified, most
likely because of the poor quality of the samples. A com-
parison of intrasubtype diversity was determined for our
50 C2V3C3 sequences and for 181 DRC C2V3C3
sequences from 1997 (1, GenBank, http://www.ncbi.nlm.
nih.gov/) with known subtype assignments (Table 1).
Unclassifiable sequences were omitted from this analysis.
We found the intrasubtype variability was already high in
the mid-1980s (9.6%–18.7%) yet was significantly greater
for each 1997 env subtype with sufficient numbers for
comparisons (A, C, D, E, F1, G). No significant change
was found in the frequency of each subtype (Table 1). 
Figure 1 represents a neighbor-joining tree containing
the following classifiable and unclassifiable C2V3C3
sequences: 56 of our early sequences from Kinshasa, 197
from the DRC collected in 1997 (subtype classifications
taken from the V3–V5 sequences published in GenBank),
and subtype-specific reference sequences. Some sequences
that were difficult to classify in trees containing just our
1980s Kinshasa sequences and subtype-specific reference
strains (data not shown) were easier to classify in the con-
text of the larger combined Zaire/DRC phylogenetic tree.
At least one of our early strains clustered with subtypes A,
B/D, C, D, F (F1), G, H, J, and K, and the circulating
recombinant form (CRF)01-AE clustered with 1997
CRF01 sequences. Also, some of our unclassifiable
sequences clustered with 1997 unclassifiable DRC strains.
One major clade contained subtype Asequences; however,
at least four other distinct lineages branched independent-
ly in the tree, yet also contained 1997 sequences previous-
ly identified as subtype A viruses. One of these lineages
that contained 1997 sequences previously designated as
subtype A or unclassifiable also contained CRF01-AE
strains in the apical portion of the cluster. Three additional
unique lineages are present in the tree composed of unclas-
sifiable sequences, perhaps representing new subtypes.
Unclassifiable 1997 sequences also branched between the
F1 and F2 lineages along with one of our 1980s strains,
which suggests a continuum of diversity within subtype F
strains instead of distinct sub-subtypes. 
Even the node connecting the subtype B and D
sequences was no longer distinct because of sequences
falling basal to the two lineages, which made the subtype
B strains appear to be part of a larger subtype D group. The
1997 sequence labeled D.3 in the tree [97DC.KS26 (acces-
sion no. AJ404096)] possibly contained a recombinant
breakpoint, which caused it to branch very deep along the
D lineage. However, our sequence 30884 also fell outside
the node connecting subtypes B and D. In fact, this strain
significantly clustered within the node connecting sub-
types B and D in p17, C2V3C3, and gp41, yet did not sig-
nificantly cluster with either subtype. A combined
Zaire/DRC consensus sequence was constructed and used
as an outgroup in this tree. The branch representing this
sequence was very short and was located close to the cen-
ter of the tree.
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Table 1. Comparison of intrasubtype/CRF
a genetic distances and subtype distribution 
Kinshasa: mid-1980s  DRC: 1997 
Subtype/CRF  n  Nucleotide distance (%)  % frequency of subtype  n  Nucleotide distance (%)  % frequency of subtype 
A  22  15.1  44  84  20.8
b  46 
C  3  13.1  6  18  18.0
b  10 
D  10  12.1  20  23  18.7
b  13 
CRF01-AE  3  9.6  6  4  17.9
b  2 
G  5  15.6  10  15  20.1
b  8 
F1  3  10.0  6  7  14.8
b  4 
H  2  18.7  4  16  23.5  9 
J  1  –  2  7  21.2  4 
K  1  –  2  7  20.4  4 
aCRF, circulating recombinant forms; DRC, Democratic Republic of Congo. 
bSignificant difference (distances significance test = t test, frequency of subtypes significance test = Fisher exact test). To determine an estimate of potentially “pure” sub-
types, we analyzed 66 of our mid-1980s HIV strains from
which we were able to amplify and sequence two or three
gene regions: 53 (80.3%) viruses were amplified in all
three gene regions (p17, C2V3C3, and gp41). Figure 2
shows the viruses with concordant phylogenies (possibly
pure subtypes) in the sequenced gene regions as follows:
A(27%), C (3%), D (18%), F1 (2%), G (8%), K (3%), and
our unusual B/D virus (2%). The remaining 37% of the
strains represented recombinant viruses; 32% of these
appeared to be unique recombinants, except where indi-
cated in Table 2, and 5% were CRF01_AE, a mosaic line-
age containing predominantly subtype Aand a unique env
lineage called E. Not only was this circulating recombi-
nant form present by the mid-1980s, but only env sub-
types A, D, and G were more prevalent. Some of the
discrepant gene regions possibly indicate the presence of
dual/multiple infections, and the sets of specific gene
region primers selectively amplified different strains.
However, since our hospital worker population does not
represent a high-risk group, the prevalence of infections in
Kinshasa was low, and recombinant viruses are generally
rapidly observed following dual infections (20), we
henceforth refer to samples with discordant gene regions
as recombinant viruses. 
Discussion
Despite a low frequency of HIV infections in Zaire in
the mid-1980s compared to the level of infections current-
ly observed in Africa, we found a remarkably high diversi-
ty of HIV-1 strains, with gene regions representing all the
group M clades as well as unclassifiable regions.
Intrasubtype diversity was already high among our sam-
ples, indicating that the HIV epidemic in Kinshasa was
already mature by the mid-1980s. No significant change
was seen in the frequency of group M subtypes between
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Figure 1. Neighbor-joining tree of 56
Zaire strains from the mid-1980s, 197
Democratic Republic of the Congo
(DRC) strains from 1997, and subtype-
specific reference strains. The number of
nucleotides in the final alignment was
304 bp after gap stripping. The model of
evolutionary change used in the tree was
the Transversional Model (TVM) +g
(0.8575), where g is the shape parame-
ter of the γ distribution (heterogeneity
among sites) and TVM is the model of
substitution whereby A↔G = C↔T and
the other four rates, all transversions, are
unique. Our 1980s C2V3C3 sequences
are indicated by a five-digit code, and
their branches are red; the 1997
sequences have the subtype (as indicat-
ed in GenBank) as the first letter, fol-
lowed by a one- or two-digit number or
the designation unk = unclassifiable, and
these branches are black; the reference
strains have the subtype as the first let-
ter followed by the reference name as
follows: A.SE7253, A.92UG037,
A2.CDK, A2.Cy017; B.HXB2, B.MN;
C.ETH2220, C.IN21068; D.84ZR085,
D.NDK, MAL; E.CD402, E.CM240,
E.TH253; F1.FIN9363, F1.93BR020;
F2.CMMP255, F2.CMMP257, G.NG083,
G.SE6165; H.90CF056, H.VI991,
J.SE91733, J.SE92809; K.96CMMP253,
and K.97REQTB; these branches are
purple. Subtype characterizations of the
phylogenetic clusters in the tree are indi-
cated in bold, lineages consisting of
unclassifiable sequences are designated
as U. A larger version of this figure is
available from http://www.cdc.gov/nci-
dod/eid/vol10no7/03-0904-G1.htmour early Kinshasa strains and a set of DRC samples col-
lected in 1997 (1), despite political and social upheavals
from 1986 to 1997.
We hypothesized that if the HIV epidemic originated in
central Africa, phylogenetic analysis of our 1984/1986
Kinshasa and 1997 DRC C2V3C3 sequences might pro-
vide a more detailed history of HIV-1 evolution. We found
a spectrum of diversity both within and between currently
recognized HIV-1 group M subtypes and sub-subtypes
(Figure 1). Some lineages, thought to represent discrete
subtypes (or sub-subtypes) within the current global epi-
demic, no longer appeared distinct when analyzed in the
context of the large diversity within Zaire/DRC sequences,
i.e., multiple, distinct C2V3C3 subtype A lineages; new
lineages containing unclassifiable strains; a continuum of
diversity within and between the F1 and F2 sub-subtypes;
and deep, unclassifiable branches. These findings demon-
strate that the HIV diversity in the mid-1980s in Kinshasa
was far more complex than in strains currently found in
other parts of the world. 
Another finding was the placement of C2V3C3
sequences of CRF01-AE in the apical branches of a line-
age containing subtype A and unclassifiable sequences as
basal branches. CRF01-AE is generally believed to be a
recombinant virus with gag and pol genes sharing a com-
mon ancestry with subtype A, while the env and vpu genes
are derived from a currently unknown parental strain, sub-
type E. However, others hypothesize that the unique sub-
type E portion of envelope is not a result of recombination
(21) but may be because a higher evolutionary rate in the
env and vpu genes make it unrecognizable as subtype A.
Our data may be the first demonstration of subtype E env
sequences grouping within a cluster of subtype A and pre-
viously unclassifiable sequences.
Acombined Zaire/DRC consensus sequence used as an
outgroup was very short and located near the center of the
tree, close to the expected location of the hypothetical
ancestor of the HIV-1 group M subtypes. This finding,
along with the complexity of the combined phylogenetic
tree, supports the theory that the group M subtypes
evolved from a common ancestor, which may have origi-
nated in this part of Africa.
Since less than 1/10 of the genome was sequenced and
analyzed in the present study, and recombination can occur
anywhere along the genome, 37% recombinant viruses is
very likely a significant underestimate of the actual fre-
quency of chimeric strains cocirculating in Kinshasa by the
mid-1980s. In fact, most HIV-1 strains may have contained
recombinant genomes by that time. Unfortunately, our data
do not allow us to discriminate whether this level of
recombination through superinfection intensified the fit-
ness of HIV strains at that time or merely contributed to
viral diversity. 
Although the precise ancestry of HIV-1 is still uncer-
tain, it appears to have a zoonotic origin (8,9). Ecologic
factors that would have allowed human exposure to a nat-
ural nonhuman primate host carrying a precursor virus to
HIV were therefore instrumental in introducing the virus
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Figure 2. Distribution of subtypes and recombinant viruses. The
pie chart represents 66 strains for which sequences from at least
2–3 gene regions were available for comparison; the subtypes in
the pie chart represent concordant phylogenies suggestive of pos-
sible “pure” subtypes; the CRF01 and unique recombinant viruses
are indicated in the pie chart. Table 2 summarizes subtypes of
unique recombinant viruses.
Table 2. Subtypes of unique recombinant viruses shown in  
Figure 2. 
  Specific gene region 
Viruses
a  P17  C2V3C3  Gp41 
n = 2  D  F1  F1 
  G  A  A 
  ?  H  A 
  A  H  G 
  A  G  G 
  A  A  G 
n = 2  A  –  G 
  ?  –  G 
  A  H  H 
  A  A  ? 
  ?  ?  ? 
  C  C  ? 
  A  –  ? 
  F1  A  ? 
  A  ?  A 
n = 3  A  ?  A 
n = 2  J  ?  ? 
aExcept where noted, each row represents a single virus.  into humans. This fact suggests that zoonotic introductions
of HIVmay have occurred in isolated populations but went
unnoticed as long as the recipients remained isolated (11)
(Figure 3A). However, with increasing movements from
rural areas to cities, which occurred in sub-Saharan Africa
during the 1960s and 1970s, such isolation became, or was
becoming, increasingly rare. The number of sub-Saharan
African cities with >500,000 inhabitants rapidly increased
from 3 in 1960 to 28 by 1980 (23). From 1965 to 1985, the
proportion of the total population living in urban areas of
central Africa rose from 21% to 35% and in western Africa
from 17% to 29%. 
Transmission of HIV would have amplified among
high-risk populations, such as commercial sex workers,
where HIV superinfections generating recombinant virus-
es could have resulted (Figure 3B). These recombinants
could then have been spread to other, lower risk persons,
such as men who visit female sex workers, their spouses,
other heterosexual partners, and persons at highest risk for
sexually transmitted diseases (24). Other transmission
routes could also have helped create and spread recombi-
nant viruses. For example, in 1986, studies from Kinshasa
showed a strong association between receiving medical
injections and HIV seropositivity among HIV-seropositive
infants born to seronegative mothers (25), among hospital-
ized children 2–14 years of age (26), and among healthcare
workers (27). Demand for blood transfusions was also
high because of malaria-associated anemia, pregnancy-
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Figure 3. Hypothetical model of HIV-1, group M evolu-
tion. A. Star phylogeny representing the evolution of the
ancestral HIV-1, group M virus that was able to adapt in
humans and was transmitted among rural populations
in central Africa from approximately the 1930s (22).
Over time, the viruses would have become increasing-
ly genetically distinct from each other and the original
parental strain. The dotted circle denotes the beginning
of migration from these remote areas to cities in central
Africa (approximately 1960–1970). B. Recombinant lin-
eages (outside the dotted circle) represented by multi-
colored lines indicating mosaic viruses or genetic mixes
of the circulating strains, would have been the result of
population migration, urbanization, patterns of sexual
activity, and medical practices (two of the oldest, fully
characterized sequences, MAL [1985] and Z321
[1976], were both recombinant viruses from Zaire).
Recombinant viruses would have continued to be gen-
erated and transmitted until introduced into high-risk
populations, such as commercial sex workers, taxi driv-
ers, commercial truck drivers, or long-distance truck
drivers, and then rapidly transmitted within and
between these social networks. Such high-risk social
networks throughout central Africa were responsible for
the rapid expansion of a relatively small number of
evolving viruses, including recombinant strains, locally,
regionally, and eventually globally. These epidemiolog-
ic groupings are represented as clusters of highly relat-
ed strains at the end of a few HIV-1 lineages. Panel C
shows what phylogenetic analysis of global HIV-1
strains collected in the early 1990s, when sequence
characterization first began, and after being exported
out of central Africa, would have looked like. The clus-
ters of related sequences from founder viruses, which
were disseminated globally, would have appeared as
subtypes or clades, arbitrarily labeled a–e.
Occasionally, strains that were not widely expanded
were identified and designated as unclassifiable. From
this hypothetical modeling, and the high numbers of
recombinant strains, it seems unlikely that only pure
subtypes were exported from this region of Africa to
establish mini-epidemics in other countries. Therefore,
at least some of what we currently define as pure sub-
types most likely arose from recombinant genomes
originally generated somewhere in central Africa.related complications, and sickle-cell anemia (28,29); at
this time, blood was generally not screened for HIV infec-
tion (30). Therefore, many factors associated with popula-
tion migration and urbanization, patterns of sexual activity,
and medical practices could have played roles in produc-
ing and spreading high numbers of recombinant viruses in
Kinshasa by the mid-1980s.
When HIV subtypes were initially genetically charac-
terized in the early 1990s, the first identified viruses were
assumed to represent pure subtypes, and viruses found
afterward were compared to these prototypic strains.
However, our data demonstrate that substantial intersub-
type recombination had already occurred at the time when
HIV-1 viruses were initially classified (Figure 3C). With so
many recombinant viruses present at the cusp of the glob-
al HIV epidemic, at least some of the recombinant viruses
in central Africa were likely classified as pure subtypes
after being exported from Africa and establishing regional
epidemics in other parts of the world. This realization
could affect our current understanding of the range of
diversity within the HIV epidemic (http://hiv-
web.lanl.gov/content/hiv-db/REVIEWS/PEETERS2000/
Peeters.html); of immunogen selection for vaccine design
(31,32), especially in light of superinfections involving
multiple subtypes (33); and of mathematical models based
on molecular clocks and nonrecombinant strains
(22,34,35) for dating the introduction of HIV into humans. 
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